Alzheimer’s disease as a metabolic disorder
OCL, 25 4 (2018) D403
Published online: 2018-08-29
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease
Steven N. Austad, Scott Ballinger, Thomas W. Buford, et al.Acta Pharmaceutica Sinica B 12 (2) 511 (2022)
https://doi.org/10.1016/j.apsb.2021.06.014
Optimization of measurement of mitochondrial electron transport activity in postmortem human brain samples and measurement of susceptibility to rotenone and 4-hydroxynonenal inhibition
Gloria A. Benavides, Toni Mueller, Victor Darley-Usmar and Jianhua ZhangRedox Biology 50 102241 (2022)
https://doi.org/10.1016/j.redox.2022.102241
Insulin Resistance as a Common Link Between Current Alzheimer’s Disease Hypotheses
Suélen Santos Alves, Rui Milton Patrício da Silva-Junior, Gabriel Servilha-Menezes, et al.Journal of Alzheimer's Disease 82 (1) 71 (2021)
https://doi.org/10.3233/JAD-210234
The Role of Metals in Neurodegenerative Diseases of the Central Nervous System
Afshin Montazeri, Milad Akhlaghi, Ahmad Reza Barahimi, Ali Jahanbazi Jahan Abad and Reza JabbariThe Neuroscience Journal of Shefaye Khatam 8 (2) 130 (2020)
https://doi.org/10.29252/shefa.8.2.130